QT
ALT icon

Quantbot Technologies’s Altimmune ALT Stock Holding History

Quantbot Technologies’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-60
Closed -$433 – 1443
2024
Q4 		$433 Buy
+60
New +$458 ﹤0.01% 1413
2023
Q4 		– Sell
-15,300
Closed -$39.8K – 1543
2023
Q3 		$39.8K Buy
+15,300
New +$43.9K ﹤0.01% 1282
2023
Q2 		– Sell
-2,077
Closed -$8.77K – 1539
2023
Q1 		$8.77K Sell
2,077
-11,518
-85% -$137K ﹤0.01% 1418
2022
Q4 		$224K Sell
13,595
-8,943
-40% -$100K 0.02% 858
2022
Q3 		$287K Buy
+22,538
New +$333K 0.02% 768

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's ALT Position: Q1 2025 in Review

Quantbot Technologies sold out of Altimmune (ALT) in Q1 2025, closing a stake of 60 shares — an estimated $433 sold.

Quantbot Technologies first reported a position in ALT in Q3 2022 and held it in 5 quarters. The position peaked at $287K in Q3 2022. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • Quantbot Technologies reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • Quantbot Technologies sold 60 Altimmune shares in Q1 2025, an estimated $433.
  • Quantbot Technologies first reported a position in Altimmune in Q3 2022 and held it in 5 quarters.
  • Quantbot Technologies's Altimmune position peaked at $287K in Q3 2022.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on Quantbot Technologies's 13F filing for Q1 2025, filed 13 May 2025.